Article
Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer.
BMC medicine - 13 Oct 2023
Nimptsch Katharina, Aleksandrova Krasimira, Pham Thu Thi, Papadimitriou Nikos, Janke Jürgen, Christakoudi Sofia, Heath Alicia, Olsen Anja, Tjønneland Anne, Schulze Matthias B, Katzke Verena, Kaaks Rudolf, van Guelpen Bethany, Harbs Justin, Palli Domenico, Macciotta Alessandra, Pasanisi Fabrizio, Yohar Sandra Milena Colorado, Guevara Marcela, Amiano Pilar, Grioni Sara, Jakszyn Paula Gabriela, Figueiredo Jane C, Samadder N Jewel, Li Christopher I, Moreno Victor, Potter John D, Schoen Robert E, Um Caroline Y, Weiderpass Elisabete, Jenab Mazda, Gunter Marc J, Pischon Tobias
Abstract excerpt
BACKGROUND: Fatty acid binding protein 4 (FABP-4) is a lipid-binding adipokine upregulated in obesity, which may facilitate fatty acid supply for tumor growth and promote insulin resistance and inflammation and may thus play a role in colorectal cancer (CRC) development. We aimed to investigate the association between circulating FABP-4 and CRC and to assess potential causality using a Mendelian randomization...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
